These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8889677)

  • 1. Development and validation of a nonisotopic immunoassay for the detection of LSD in human urine.
    Cassells NP; Craston DH; Hand CW; Baldwin D
    J Anal Toxicol; 1996 Oct; 20(6):409-15. PubMed ID: 8889677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples.
    Wiegand RF; Klette KL; Stout PR; Gehlhausen JM
    J Anal Toxicol; 2002 Oct; 26(7):519-23. PubMed ID: 12423010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An online immunoassay for LSD: comparison with GC-MS and the Abuscreen RIA.
    McNally AJ; Goc-Szkutnicka K; Li Z; Pilcher I; Polakowski S; Salamone SJ
    J Anal Toxicol; 1996 Oct; 20(6):404-8. PubMed ID: 8889676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoassay analysis of lysergic acid diethylamide.
    Cody JT; Valtier S
    J Anal Toxicol; 1997 Oct; 21(6):459-64. PubMed ID: 9323526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and interpretation of lysergic acid diethylamide results by immunoassay screening of urine in various testing groups.
    Wu AH; Feng YJ; Pajor A; Gornet TG; Wong SS; Forte E; Brown J
    J Anal Toxicol; 1997; 21(3):181-4. PubMed ID: 9171199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical extraction and detection of LSD in whole blood.
    Kerrigan S; Brooks DE
    J Immunol Methods; 1999 Apr; 224(1-2):11-8. PubMed ID: 10357201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a commercial radioimmunoassay kit for the detection of lysergide (LSD) in serum, whole blood, urine and stomach contents.
    Altunkaya D; Smith RN
    Forensic Sci Int; 1990 Sep; 47(2):113-21. PubMed ID: 2227729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoassay screening of lysergic acid diethylamide (LSD) and its confirmation by HPLC and fluorescence detection following LSD ImmunElute extraction.
    Grobosch T; Lemm-Ahlers U
    J Anal Toxicol; 2002 Apr; 26(3):181-6. PubMed ID: 11991536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indirect enzyme-linked immunosorbent assay for the quantitative estimation of lysergic acid diethylamide in urine.
    Kerrigan S; Brooks DE
    Clin Chem; 1998 May; 44(5):985-90. PubMed ID: 9590371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirmation of LSD intoxication by analysis of serum and urine.
    McCarron MM; Walberg CB; Baselt RC
    J Anal Toxicol; 1990; 14(3):165-7. PubMed ID: 2374406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of commonly used adulterants on the detection of spiked LSD by an enzyme immunoassay.
    Cassells NP; Craston DH
    Sci Justice; 1998; 38(2):109-17. PubMed ID: 9624820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoassay of lysergic acid diethylamide (LSD) in serum and urine by using antisera of different specificities.
    Ratcliffe WA; Fletcher SM; Moffat AC; Ratcliffe JG; Harland WA; Levitt TE
    Clin Chem; 1977 Feb; 23(2 PT. 1):169-74. PubMed ID: 832379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference with testing for lysergic acid diethylamide.
    Ritter D; Cortese CM; Edwards LC; Barr JL; Chung HD; Long C
    Clin Chem; 1997 Apr; 43(4):635-7. PubMed ID: 9105265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development and evaluation of a 125I radioimmunoassay for the measurement of LSD in body fluids.
    Stead AH; Watton J; Goddard CP; Patel AC; Moffat AC
    Forensic Sci Int; 1986; 32(1):49-60. PubMed ID: 3770601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analysis of lysergide (LSD): the development of novel enzyme immunoassay and immunoaffinity extraction procedures together with an HPLC-MS confirmation procedure.
    Webb KS; Baker PB; Cassells NP; Francis JM; Johnston DE; Lancaster SL; Minty PS; Reed GD; White SA
    J Forensic Sci; 1996 Nov; 41(6):938-46. PubMed ID: 8914284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the diagnostic performance of the Boehringer Mannheim CEDIA LSD assay.
    Verstraete AG; Steyaert S
    J Anal Toxicol; 1998; 22(7):601-4. PubMed ID: 9847012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of lysergic acid diethylamide in human urine: elimination, screening and analytical confirmation].
    Vu-Duc T; Vernay A; Calanca A
    Schweiz Med Wochenschr; 1991 Dec; 121(50):1887-90. PubMed ID: 1759150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a rapid turboflow LC-MS/MS method for the quantification of LSD and 2-oxo-3-hydroxy LSD in serum and urine samples of emergency toxicological cases.
    Dolder PC; Liechti ME; Rentsch KM
    Anal Bioanal Chem; 2015 Feb; 407(6):1577-84. PubMed ID: 25542574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development and application of a gas chromatography-mass spectrometric (GC-MS) assay to determine the presence of 2-oxo-3-hydroxy-LSD in urine.
    Burnley BT; George S
    J Anal Toxicol; 2003; 27(4):249-52. PubMed ID: 12820748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New synthesis and characterization of (+)-lysergic acid diethylamide (LSD) derivatives and the development of a microparticle-based immunoassay for the detection of LSD and its metabolites.
    Li Z; Goc-Szkutnicka K; McNally AJ; Pilcher I; Polakowski S; Vitone S; Wu RS; Salamone SJ
    Bioconjug Chem; 1997; 8(6):896-905. PubMed ID: 9404664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.